Patent ID: 8535683
Filing Date: 2013-09-17
Classification: A61K,C12N

Abstract:
1. A method of inducing an immune response against one or more influenza strains, comprising administering to a human being a single intranasal or inhalational dose of a vaccine formulation comprising a composition of influenza virosomes, wherein the virosomes comprise reconstituted influenza virus envelopes from one or more influenza strains, wherein the viral envelopes are derived entirely from influenza viral particles, wherein no lipid from an external source is added to the virosomes, wherein the virosomes comprise the influenza antigen haemagglutinin, wherein no separate adjuvant, immune stimulator, or adjuvant and immune stimulator is added to the composition, wherein the vaccine is designed for a single intranasal or inhalational administration to a human being, and wherein the dose of haemagglutinin per viral strain per single intranasal or inhalational administration is lower than or equal to 30 μg.